Fennec Pharmaceuticals (STU:RV41) Accounts Payable : €4.79 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Fennec Pharmaceuticals Accounts Payable?

Fennec Pharmaceuticals's Accounts Payable for the quarter that ended in Mar. 2024 was €4.79 Mil.

Fennec Pharmaceuticals's quarterly Accounts Payable increased from Sep. 2023 (€2.76 Mil) to Dec. 2023 (€3.46 Mil) and increased from Dec. 2023 (€3.46 Mil) to Mar. 2024 (€4.79 Mil).

Fennec Pharmaceuticals's annual Accounts Payable increased from Dec. 2021 (€0.69 Mil) to Dec. 2022 (€2.26 Mil) and increased from Dec. 2022 (€2.26 Mil) to Dec. 2023 (€3.46 Mil).

Fennec Pharmaceuticals Accounts Payable Historical Data

The historical data trend for Fennec Pharmaceuticals's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fennec Pharmaceuticals Accounts Payable Chart

Fennec Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

1.45

1.29

0.69

2.26

3.46

Fennec Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable	Get a 7-Day Free Trial															2.75	2.77	2.76	3.46	4.79

Fennec Pharmaceuticals Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Fennec Pharmaceuticals Accounts Payable Related Terms

Thank you for viewing the detailed overview of Fennec Pharmaceuticals's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Fennec Pharmaceuticals (STU:RV41) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fennec Pharmaceuticals Inc (STU:RV41) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

FENC:USA FRX:Canada

Address

68 TW Alexander Drive, PO Box 13628, Research Triangle Park, NC, USA, 27709

Website

https://www.fennecpharma.com

Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Fennec Pharmaceuticals (STU:RV41) Headlines

No Headlines